Amazon FBA • Cosmetics • OTC Drugs • U.S. FDA Compliance
Shipping Cosmetics to Amazon U.S. Warehouses and Selling FDA-Regulated Beauty and Personal-Care Products
A practical compliance guide for domestic and foreign manufacturers, exporters, Amazon sellers, importers, distributors, responsible persons, and brands placing conventional cosmetics or cosmetic-drug combination products on the U.S. market.
Introduction
Amazon Warehouses Do Not Replace FDA Compliance
Shipping cosmetics to Amazon fulfillment centers in the United States can create access to one of the world’s largest retail marketplaces. Through Fulfillment by Amazon, commonly called FBA, a seller may send inventory to designated Amazon warehouses, allow Amazon to store the products, and use Amazon’s fulfillment network to pick, pack, and deliver customer orders. That commercial convenience, however, does not transfer the seller’s regulatory duties to Amazon.
A product must be lawful before it is offered for import, shipped to a U.S. warehouse, listed online, or delivered to a consumer. Amazon may impose its own documentation, packaging, testing, dangerous-goods, shelf-life, labeling, listing, and category restrictions in addition to federal and state requirements. Amazon can suppress an ASIN, reject inbound inventory, dispose of units, restrict a category, request laboratory reports, or suspend selling privileges even when FDA has not initiated a public enforcement action.
The most important first step is proper product classification. Many items marketed by the beauty and personal-care industry are conventional cosmetics. Others are drugs because they are intended to treat, prevent, mitigate, or cure disease, or because they are intended to affect the structure or function of the body. Some products are both cosmetics and drugs. Sunscreen, antidandruff shampoo, fluoride anticavity toothpaste, antiperspirant, many cold and cough products, laxatives, skin protectants, vaginal contraceptives, certain weight-control products, and hand sanitizers are not regulated only as conventional cosmetics. Their active ingredients, indications, warnings, manufacturing operations, drug listings, establishment registrations, and Drug Facts labeling may trigger the U.S. over-the-counter drug framework.
The name of an Amazon category does not determine FDA classification. FDA evaluates the product’s ingredients, intended use, claims, labeling, website content, images, advertising, consumer directions, and other evidence of intended use.
Chapter 1
Classifying Cosmetics, OTC Drugs, and Combination Products
Product classification drives nearly every later decision, including the facility obligations, label format, claims, testing program, import data, and Amazon documentation package.
Appearance, cleansing, and beautification
Examples may include makeup, perfume, ordinary moisturizing lotion, non-medicated shampoo, hair conditioner, facial cleanser, lipstick, and products intended only to cleanse, beautify, promote attractiveness, or alter appearance.
These products are generally subject to the Federal Food, Drug, and Cosmetic Act, the Fair Packaging and Labeling Act, cosmetic ingredient and color-additive rules, MoCRA, state laws, and Amazon policy.
Therapeutic or preventive intended use
A product may be a drug when claims promise disease treatment or prevention, antimicrobial action, sunburn prevention, dandruff control, cavity prevention, perspiration reduction, cough relief, constipation relief, contraception, or another therapeutic effect.
OTC drugs must follow an applicable OTC monograph or an approved drug application. A familiar ingredient alone does not make a product lawful.
Dual-purpose formulation and labeling
Antidandruff shampoo cleans hair but also treats dandruff. Fluoride toothpaste cleans and freshens while helping prevent cavities. Antiperspirant may also function as a deodorant. Sunscreen cosmetics may beautify while providing an OTC sunscreen indication.
A dual-purpose product must comply with both applicable cosmetic provisions and drug provisions.
Phrases such as “treats acne,” “heals eczema,” “kills germs,” “repairs damaged skin,” “stimulates hair growth,” “reduces inflammation,” “prevents infection,” or “clinically treats” can create drug intended use. Amazon titles, bullets, A+ Content, storefront pages, videos, influencer scripts, and package inserts should be reviewed together with the physical label.
Chapter 2
How the Listed Product Categories Are Regulated
The following grid provides a planning overview. The exact regulatory pathway depends on formulation, dosage form, active ingredients, concentrations, indications, combinations, and current FDA requirements.
Conventional cosmetics
Products such as ordinary makeup, fragrance, moisturizer, cleanser, and non-medicated hair care may be cosmetics only. Key issues include safety substantiation, ingredient and color-additive compliance, MoCRA registration and listing where applicable, adverse-event procedures, records, and cosmetic labeling.
Sunscreen
Sunscreen is an OTC drug in the United States. A moisturizer, foundation, lip product, or other beauty product with SPF or sunburn-prevention claims may be both a cosmetic and a drug. The formulation and labeling must fit the applicable sunscreen monograph conditions or an approved application.
Antidandruff shampoo
An antidandruff shampoo is generally a cosmetic-drug combination. It must satisfy applicable OTC dandruff-drug conditions for active ingredient, concentration, indications, directions, warnings, testing, and Drug Facts presentation while also meeting cosmetic ingredient labeling requirements.
Antiperspirant deodorant
A deodorant intended only to control odor may be a cosmetic. A product intended to reduce perspiration is an OTC antiperspirant drug and may also be a cosmetic. Claims such as “24-hour sweat protection” need support and must remain consistent with the lawful drug conditions.
Skin protectants
Products making skin-protectant claims may be OTC drugs. A lotion or balm can move beyond cosmetic moisturization when it claims to temporarily protect minor cuts, scrapes, burns, chapped skin, or another monograph indication. The distinction must be reflected in the formula and label.
Borderline beauty products
Acne products, hair-growth products, skin-lightening products, eyelash-growth products, medicated lip products, pain-relieving creams, and products containing prescription-only or unapproved drug ingredients require heightened review before importation or Amazon listing.
Chapter 3
MoCRA Requirements for Conventional Cosmetics
The Modernization of Cosmetics Regulation Act of 2022 significantly expanded FDA’s authority over cosmetics. Cosmetic facilities that manufacture or process cosmetic products for distribution in the United States generally must register with FDA unless an exemption applies. Facility registration must be renewed every two years, and required changes must be submitted within the applicable period.
The “responsible person”—generally the manufacturer, packer, or distributor whose name appears on the cosmetic label—must list each marketed cosmetic product with FDA and provide required updates. Product listing information includes the responsible person, product identity, facility information, product category, and ingredient information. Product listings must be updated annually when required.
Foreign cosmetic facilities subject to registration must identify a U.S. agent. The U.S. agent serves as a communications contact between FDA and the foreign facility. This role should not be confused with an FSVP importer for food, an initial importer for medical devices, an Importer of Record for customs, or the Amazon seller account owner.
Responsible person duties
- Maintain adequate substantiation of product safety.
- Submit required cosmetic product listings and updates.
- Receive adverse-event communications through the domestic contact shown on the label.
- Report serious adverse events to FDA within the required period.
- Maintain required records and cooperate with FDA requests.
- Ensure labels and marketing do not misbrand the product.
Facility duties
- Register manufacturing or processing facilities when required.
- Renew facility registrations biennially.
- Update required registration information after changes.
- Maintain hygienic, controlled manufacturing operations.
- Support traceability, complaint handling, and recall readiness.
- Prepare for future or applicable cosmetic GMP requirements.
Certain small businesses may qualify for specific MoCRA exemptions, but exemptions are limited and do not apply to every product or operation. High-risk product categories and certain manufacturing activities can be excluded from small-business relief. A business should document its exemption analysis rather than assuming that low sales or a small workforce eliminates all obligations.
Chapter 4
OTC Drug Compliance for Cosmetic-Drug Products
OTC drugs may be marketed through an applicable OTC monograph or an approved New Drug Application or Abbreviated New Drug Application. An OTC monograph functions like a rulebook for a therapeutic category. It identifies conditions under which products are generally recognized as safe and effective and are not misbranded. Those conditions may address active ingredients, concentrations, dosage forms, routes of administration, indications, directions, warnings, combinations, labeling, and testing.
A manufacturer cannot select one favorable element from a monograph and ignore the remaining conditions. A sunscreen with a recognized active ingredient can still be unlawful if the concentration, dosage form, directions, claims, broad-spectrum testing, water-resistance representation, warnings, or manufacturing controls do not comply. Similarly, a hand sanitizer cannot rely only on an alcohol percentage without addressing identity, strength, purity, impurities, labeling, production controls, and the current legal status of the formulation.
Drug establishment registration, National Drug Code-related submissions, drug listing, labeler-code coordination, current good manufacturing practice, quality-unit oversight, component controls, finished-product specifications, stability support, complaint procedures, adverse-event procedures, recall readiness, and compliant Drug Facts labeling.
Foreign drug establishments must comply with the same applicable drug requirements as domestic establishments and must identify a U.S. agent for FDA communications. Drug registration and listing do not constitute FDA approval. Likewise, obtaining an NDC does not prove that FDA approved the formula, reviewed the label, or authorized the marketing claims.
Drug products manufactured under conditions that fail current good manufacturing practice may be adulterated even when laboratory results for a particular batch appear acceptable. Amazon sellers should therefore qualify the manufacturer, review the manufacturing agreement, confirm who owns the formula and specifications, verify batch documentation, and establish access to records needed to answer Amazon or FDA questions.
Chapter 5
Labeling and Amazon Detail-Page Compliance
The physical package and the digital product listing should tell the same lawful story. Inconsistency between the two is a frequent source of Amazon enforcement and FDA misbranding risk.
Conventional cosmetic label review
- Statement of identity on the principal display panel.
- Accurate net quantity of contents.
- Ingredient declaration using appropriate cosmetic nomenclature and order.
- Name and place of business of the manufacturer, packer, or distributor.
- Domestic address, domestic telephone number, or electronic contact information for adverse-event reporting.
- Required warnings and directions for safe use.
- English-language information and adequate prominence and conspicuousness.
- Permitted color additives and compliant declaration of color ingredients.
OTC drug label review
- Drug Facts panel with required headings and formatting.
- Active ingredient and purpose.
- Uses consistent with the monograph or approved application.
- Warnings, directions, and other required information.
- Inactive ingredients in the appropriate section.
- Lot or batch traceability and expiration dating when required or supported.
- Identity statement, net contents, business information, and required package statements.
- Consistency among carton, immediate container, insert, website, and Amazon listing.
Amazon images should show the product actually shipped to the customer. The title, bullet points, description, comparison charts, A+ Content, videos, and backend search terms should not add disease claims absent from the lawful label. Before-and-after images, endorsements, “FDA approved” language, medical symbols, physician imagery, and scientific-sounding claims can create additional risk when they imply a level of review or therapeutic performance that has not been established.
Sellers should also control translations. A compliant English label can be undermined by an Amazon image, insert, or foreign-language statement making an unapproved claim. For imported products, mandatory label information generally must be available in English, subject to limited multilingual labeling rules.
Chapter 6
Safety Substantiation, Testing, and Quality Documentation
A cosmetic responsible person must ensure and maintain records supporting adequate substantiation of product safety. Safety substantiation is broader than obtaining a generic Certificate of Analysis. The appropriate evidence depends on ingredients, exposure, user population, application area, packaging, foreseeable misuse, microbiological risk, stability, impurities, allergens, and the claims being made.
A risk-based program may include raw-material specifications, supplier qualification, formula review, preservative effectiveness or challenge testing, microbial limits, stability and compatibility studies, heavy-metal screening, restricted-substance review, packaging testing, toxicological assessment, and finished-product release criteria. Eye-area products, water-based products, children’s products, skin-lightening products, aerosols, and products with unusual botanicals or high-risk ingredients may need additional controls.
OTC drug products require specifications and testing consistent with the applicable legal pathway and current good manufacturing practice. Testing should be conducted using suitable, validated or verified methods. Records should connect the laboratory result to the exact formulation, lot, manufacturing site, packaging configuration, and ASIN under review.
Keep current labels, formula and ingredient data, facility registrations, product listings, drug listings where applicable, GMP records, batch documents, COAs, safety support, test reports, SDS documents for transport classification, authorization letters, invoices, and clear product photographs in one controlled file.
Amazon may request compliance documents for selected categories or ASINs. Requirements can change by product, risk profile, marketplace, fulfillment method, and enforcement program. Sellers should follow the instructions displayed in Seller Central and verify that laboratories or service providers meet the current program criteria rather than relying on an old list copied from a forum or prior submission.
Chapter 7
Shipping Inventory to Amazon U.S. Fulfillment Centers
Regulatory clearance, customs entry, Amazon receiving, and FBA fulfillment are separate processes. A shipment can pass one process and fail another.
Confirm product legality before production
Classify the product, review ingredients and claims, determine whether it is a cosmetic, drug, cosmetic-drug combination, device, food, supplement, or another category, and identify the regulatory pathway before labels and inventory are finalized.
Complete registrations and listings
Complete applicable cosmetic facility registration, cosmetic product listing, drug establishment registration, drug listing, U.S. agent appointment, and related updates. Do not describe these submissions as product approvals.
Finalize compliant packaging
Review the principal display panel, information panel, ingredient declarations, Drug Facts where applicable, warnings, business information, adverse-event contact, lot coding, expiration dating, country-of-origin marking, and Amazon barcode requirements.
Determine transport and dangerous-goods status
Perfumes, aerosols, alcohol-based hand sanitizers, nail products, hair sprays, and pressurized or flammable products may be regulated for transportation and subject to Amazon dangerous-goods review. Accurate Safety Data Sheets and transport classification may be required.
Assign the customs and FDA entry parties
Identify the Importer of Record, customs broker, consignee, owner or purchaser, seller, warehouse destination, and other parties. Provide accurate product descriptions, tariff classifications, values, manufacturer details, and FDA data elements. Amazon should not be named as importer or consignee unless its current written program terms expressly permit the role.
Prepare the FBA shipment
Follow the current shipment plan, carton content, labeling, prep, packaging, expiration-date, temperature, leakage-prevention, poly-bagging, case-pack, pallet, and carrier requirements. FBA shipment creation does not authorize importation.
Monitor entry, receiving, and account health
Track customs release, FDA admissibility, carrier delivery, Amazon check-in, receiving discrepancies, stranded inventory, compliance requests, customer complaints, returns, and Account Health notices. Maintain a documented escalation path for each type of issue.
Chapter 8
FDA Import Compliance for Foreign Manufacturers and Exporters
Imported cosmetics and drugs must meet the same applicable U.S. requirements as domestic products. During entry review, FDA may evaluate registration and listing status, product codes, manufacturer identity, declared use, labeling, historical compliance, import alerts, and other electronic or physical evidence. Products that appear adulterated, misbranded, or unapproved may be detained or refused.
A foreign exporter should not assume that a freight forwarder, customs broker, Amazon prep center, or FBA warehouse has validated FDA compliance. Customs brokers transmit information based on documents supplied by the parties. They generally do not become the manufacturer’s regulatory department, responsible person, drug U.S. agent, cosmetic U.S. agent, or owner of the product’s safety file merely by filing an entry.
The shipment documentation should accurately identify the manufacturer and product. Vague descriptions such as “beauty goods,” “samples,” or “personal products” can cause delays and may create enforcement concerns. Commercial invoices, packing lists, bills of lading, entry data, labels, and Amazon listings should use consistent product identities.
Country-of-origin marking and customs valuation are administered primarily by U.S. Customs and Border Protection, while FDA requirements focus on the product’s safety, labeling, legal marketing status, and applicable registrations or listings. Both systems matter. A shipment released by customs can still face FDA action, and an FDA-compliant product can still encounter customs, intellectual-property, transportation, or Amazon receiving problems.
Chapter 9
Responsibilities Across the Supply Chain
Domestic or foreign manufacturer
Controls formula, ingredients, processing, specifications, quality records, batch release, and many registration or listing inputs. The manufacturer should notify the brand of material changes and provide records needed for complaints, investigations, and recalls.
Brand owner or responsible person
Controls the marketed identity and often the claims, label, product listing, safety substantiation, adverse-event contact, and Amazon content. Private-label status does not remove responsibility for the finished product.
Foreign exporter
Coordinates lawful production, export documents, shipment identity, U.S. contacts, and records. The exporter should confirm who is responsible for FDA entry data and who will respond if the shipment is held.
Importer of Record
Handles or assumes responsibility for customs entry obligations, including reasonable care regarding classification, value, origin, and admissibility documentation. This role is not automatically the cosmetic responsible person or FDA U.S. agent.
Distributor and Amazon seller
Controls distribution and marketplace representations. The seller should maintain invoices, authorization records, technical documents, complaint data, returns information, and access to the manufacturer’s compliance evidence.
Amazon and FBA warehouse
Amazon operates the marketplace and fulfillment program under its own policies. Storage and fulfillment do not make Amazon the manufacturer’s regulatory consultant or transfer the seller’s FDA compliance duties to Amazon.
Chapter 10
Complaints, Adverse Events, Recalls, and Amazon Returns
Customer feedback is a regulatory data source. A one-star Amazon review describing a hospitalization, infection, burn, eye injury, allergic reaction, unexpected drug effect, or another serious outcome should not be treated only as a reputation-management problem. The seller and responsible person need procedures to capture, assess, investigate, document, and escalate safety information.
Under MoCRA, the responsible person must report serious adverse events associated with use of a cosmetic product in the United States to FDA within 15 business days and submit qualifying new medical or other information received within one year. Labels must provide a domestic address, domestic telephone number, or electronic contact information through which adverse events can be received.
OTC drugs have separate adverse-event and recordkeeping considerations. The applicable party should assess whether a report is required, preserve the product and lot information, investigate manufacturing and distribution records, and evaluate whether other lots or products are affected.
Amazon returns can obscure lot traceability when units are commingled, relabeled, or deemed unfulfillable. Sellers should understand their barcode and inventory settings, preserve lot and expiration information, and establish instructions for removals, quarantine, destruction, and recall communication. A recall plan should address consumers, Amazon, other distributors, FDA, logistics providers, and inventory at multiple fulfillment centers.
Chapter 11
Common Compliance Failures
Regulatory failures
- Treating an OTC drug as a conventional cosmetic.
- Using an unapproved active ingredient or noncompliant concentration.
- Missing cosmetic or drug facility registration and product listing.
- Claiming that FDA registration or an NDC means FDA approval.
- Using prohibited, restricted, contaminated, or undeclared ingredients.
- Failing to maintain safety substantiation or adequate batch records.
- Submitting inconsistent manufacturer or product information at import.
- Making disease claims through Amazon content or social media.
Amazon and logistics failures
- Shipping inventory before completing category or compliance review.
- Using labels or images that differ from the delivered unit.
- Sending leaking, breakable, expired, or short-dated products.
- Failing dangerous-goods review for aerosols, perfumes, or sanitizers.
- Submitting generic COAs that do not identify the ASIN or batch.
- Naming Amazon as importer without written authorization.
- Ignoring Account Health or Manage Your Compliance deadlines.
- Lacking a plan for rejected, stranded, recalled, or returned inventory.
Chapter 12
Services Provided by U.S. FDA Consultants
A qualified FDA consultant can coordinate the regulatory workstream while manufacturers, exporters, importers, and Amazon sellers focus on production, sales, and logistics.
Product classification
Review formulation, active ingredients, intended use, claims, packaging, and digital marketing to determine whether the product is a cosmetic, OTC drug, cosmetic-drug combination, device, food, supplement, or another regulated category.
MoCRA registration and listing
Assist with cosmetic facility registration, FEI coordination, biennial renewal, cosmetic product listings, annual updates, responsible-person data, facility information, and exemption analysis.
U.S. agent service
Serve as U.S. agent for eligible foreign cosmetic or drug establishments, maintain contact procedures, support FDA communications, and route requests to the appropriate responsible personnel.
OTC drug registration and listing
Support establishment registration, labeler-code and NDC coordination, drug listing submissions, annual updates, inactive status review, and alignment between electronic listing data and labels.
Formula and monograph review
Compare active ingredients, strengths, dosage forms, indications, directions, warnings, and other conditions with the applicable OTC monograph or identify when an approved application may be needed.
Label and claims review
Review cosmetic labels, Drug Facts panels, ingredient declarations, net contents, warnings, responsible-person contacts, Amazon titles, bullets, images, A+ Content, websites, and advertising.
Amazon compliance package
Organize labels, invoices, authorization letters, registrations, product listings, test reports, COAs, GMP evidence, SDS documents, product images, and response narratives for Seller Central requests.
Quality and SOP development
Prepare or improve procedures for complaints, adverse events, batch review, supplier qualification, document control, deviations, corrective actions, recalls, returned goods, and regulatory escalation.
Import and detention support
Coordinate with importers and customs brokers, review FDA entry information, support responses to requests for documents, and assist with detention, examination, refusal, or corrective-action matters.
Testing coordination
Help define a risk-based testing plan, identify suitable laboratories, review the scope of work, connect test results to specifications and lots, and evaluate whether reports answer Amazon or FDA questions.
Inspection readiness
Conduct gap assessments, mock inspections, records review, management training, facility-response planning, and corrective-action tracking for cosmetic or OTC drug operations.
Ongoing regulatory maintenance
Track renewals, annual updates, product changes, label revisions, facility changes, new ASINs, complaints, Amazon requests, and regulatory developments that may affect continued distribution.
An FDA consultant can provide regulatory support, but the manufacturer, responsible person, labeler, importer, distributor, and seller retain their legal and contractual responsibilities. Consultants should not promise FDA approval, guaranteed customs release, guaranteed Amazon acceptance, or immunity from enforcement.
Chapter 13
A Pre-Shipment Compliance Checklist
Regulatory readiness
- Product classification documented.
- Formula and ingredient review completed.
- OTC monograph or application pathway confirmed where applicable.
- Facility registrations and product listings active.
- Foreign-facility U.S. agent appointed where required.
- Label and claims review completed.
- Safety substantiation and testing records available.
- Complaint and adverse-event procedures operational.
Amazon and shipment readiness
- Amazon listing matches the physical product.
- Current Seller Central requirements reviewed.
- Dangerous-goods status and SDS documentation confirmed.
- Expiration, lot coding, and shelf-life rules addressed.
- Importer of Record and customs broker confirmed.
- FDA entry data and commercial documents verified.
- FBA carton, labeling, prep, and routing rules followed.
- Plan established for holds, refusals, returns, and recalls.
Conclusion
Build Compliance Before Inventory Reaches the Warehouse
Successful Amazon cosmetics sales begin long before an FBA shipment plan is created. They begin with correct classification, lawful ingredients, controlled manufacturing, accurate registrations and listings, compliant labeling, defensible claims, reliable testing, and a supply chain that knows who is responsible for each regulatory and logistics function.
Conventional cosmetics and OTC cosmetic-drug products cannot be managed under one generic checklist. Sunscreen, antidandruff shampoo, fluoride toothpaste, antiperspirant, hand sanitizer, and other therapeutic products require drug-specific analysis. Cold and cough products, laxatives, vaginal contraceptives, and many weight-control products require their own pathways and should not be treated as ordinary beauty items simply because Amazon places them near cosmetics or personal care.
Foreign manufacturers and exporters face an additional layer of import and U.S. contact obligations. Domestic manufacturers, importers, distributors, private-label brands, and Amazon sellers must also maintain records and respond effectively to FDA, customs, Amazon, and consumer safety issues. The most economical approach is preventive: resolve classification, formula, label, registration, listing, testing, transport, and import questions before producing large quantities or shipping inventory.
Prepare Your Cosmetics or OTC Products for FDA Compliance and Amazon U.S. Fulfillment
ITB HOLDINGS LLC assists domestic and foreign manufacturers, exporters, importers, distributors, brand owners, and Amazon sellers with product classification, MoCRA registration and listing, OTC drug registration and listing, U.S. agent service, formula and label review, Amazon compliance documentation, import support, SOP development, adverse-event readiness, and regulatory maintenance.
Before shipping inventory to an Amazon U.S. warehouse, request a product-specific compliance review. Early review can help identify misclassification, prohibited claims, missing registrations, incomplete labels, unsuitable testing, dangerous-goods concerns, and import problems before they become costly listing suspensions, detentions, removals, returns, or recalls.
